Why a general reply is not enough for targeted therapy
Targeted cancer treatment acts on particular molecular features, and biomarker findings can help clinicians assess potential treatment options. That makes your case more specific than a general oncology enquiry. The department that reviews a new diagnosis may not be the one that manages an ongoing targeted drug, and a reply from a hospital's general mailbox may not come from either.
A message such as "we can help" or "please come to our hospital" does not tell you who will see you, at which campus, or whether the visit is a consultation, a records review or an admission step. For an overseas patient, that gap matters because travel, accommodation and time away from current care all depend on it.
The practical goal is not to collect warm replies. It is to get a written answer that names the clinical unit, the location and the type of appointment, and that responds to your actual biomarker and drug context.
The three things to confirm in writing
Treat the confirmation as three separate items, because a reply can settle one and leave the others open.
First, the department. Ask for the specific clinical unit that would assess your case, not just the hospital name. For targeted therapy this may sit within medical oncology, but the correct unit depends on your tumour type and treatment history, so ask the receiving centre to state it rather than assuming.
Second, the campus. Large hospitals can run several sites, and oncology services may not all be at the same address. Ask which campus the appointment is at and whether the relevant tests or infusion facilities are at that same site.
Third, the appointment type. Ask whether the offer is a first consultation, a records-based opinion, a follow-up visit, or a step toward admission. These are different commitments, and only the hospital can say which one it is offering.
If any of the three is missing, you do not yet have a confirmed appointment. Ask again, quoting the unanswered item.
What the centre needs to assess your drug and biomarker context
Before a centre can say whether it can assess your case, it needs the molecular and treatment picture, not a summary of your diagnosis alone. The useful items are the ones that describe what has already been tested and what you are taking now.
Prepare a short list you can send or bring: the tumour type and stage as recorded by your treating team, the biomarker or molecular test reports you already have, the names of targeted drugs you have received or are receiving, the dates and doses as prescribed, the most recent imaging and blood results, and a plain statement of your main question.
You do not need to send a complete archive at first contact. A brief summary is enough to start, and you can share fuller records once a clinical unit is identified. Do not send passport numbers or payment details in an initial enquiry.
Ask the centre directly whether it can assess your specific drug and biomarker history. If it cannot, that is useful information, and it is better to learn it before booking travel.
How ongoing treatment and monitoring would continue
If you are already on a targeted drug, the practical question is not only whether a centre will see you, but how treatment and monitoring would continue around the visit. Ask how the receiving team would handle your current medication during assessment, what monitoring it would want, and how any change would be communicated to your existing clinicians.
Do not change or pause prescribed medication on the basis of an enquiry or a travel plan. That decision belongs to your treating clinicians. If you have worsening symptoms, seek local care first rather than waiting for an overseas appointment.
Ask what the centre would need from your current team, and whether it would contact them directly. Also ask what it can and cannot confirm before you arrive, so you are not treating a provisional clinical stage as a settled plan.
What a reply does and does not confirm
A written reply that names the department, campus and appointment type confirms the administrative route. It does not confirm that you are suitable for a particular drug, that a medicine is available, or that the hospital has accepted you for treatment. Suitability and acceptance are decisions for the treating hospital and its clinicians.
Read the reply for the exact wording. "We can arrange a consultation" is not the same as "the medical oncology unit at this campus will review your file on this date." "Your records have been received" is not the same as "a clinician has assessed your biomarker and drug history." "You may come to our hospital" is not the same as "you have been accepted for treatment." Each of these phrases leaves a different question open, and the open question is the one to send back.
A records-based opinion is also not the same as a diagnosis made in person, and it does not establish final eligibility or hospital acceptance. A remote review can describe what a file shows and what a clinician would want to examine further, but it cannot replace an in-person assessment, and it does not commit the hospital to treating you. Keep the unanswered questions on your list and treat each reply as a partial answer until the three items are named.
If a reply names the department but not the campus, ask which site. If it names the campus but not the appointment type, ask whether the offer is a consultation, a records review or a step toward admission. If it names all three but does not mention your specific drug or biomarker, ask whether the unit can assess that history. One question per reply keeps the exchange clear and makes it easier to see what has actually been settled.
Where a reply is silent on cost, ask for the provider's written quote and what it includes, excludes or leaves undecided. Do not assume a component is or is not charged separately; ask the named provider about its own quote. A quote that does not state its scope is not yet a quote you can plan around.
Keep every reply in one place, with the date and the name of the unit that sent it. If you later contact a second centre, you can compare answers to the same three questions rather than comparing general impressions. That comparison is more useful than any single warm reply, because it shows which centre has actually engaged with your file.
If a step cannot be completed, and the next practical move
Sometimes a centre will not name a department before reviewing records, or will not confirm an appointment type until a clinician has seen your file. That is a normal sequence, not a refusal. In that case, ask what specific document or answer would move the request forward, and send only that.
If you cannot obtain a clear answer from one route, you can ask a second centre the same three questions and compare the replies. Keep your current care in place while you do this.
For records, interpretation or a specialist appointment request, confirmed coordination can help with the administrative steps as supported by the relevant service. It does not decide clinical suitability, prescriptions or availability.
A practical next step is to write your three questions, attach your biomarker and drug list, and send a short initial enquiry. An initial enquiry is free, and you do not need to buy a proxy consultation to ask whether a centre can assess your case.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.